日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Insights on Oligometastatic Non-Small-Cell Lung Cancer

寡转移性非小细胞肺癌的见解

Valdivia, Augusto; Mascaro-Baselga, Pau; Salva-de Torres, Clara; Geng-Cahuayme, Abraham; Torresan, Sara; Yaringaño, Jesus; Priano, Ilaria; Iranzo, Patricia; Pardo, Nuria; Masfarre, Laura; Mirallas, Oriol; Farfan, Karen; Cedres, Susana; Rocha, Pedro; Martinez-Marti, Alex; Felip, Enriqueta

Real-World Data of First-Line Cemiplimab Monotherapy for Metastatic Non-Small Cell Lung Cancer (NSCLC) with PD-L1 Expression ≥ 50%: A National Spanish Multicentric Cohort (CEMI-SPA Study)

Cemiplimab 一线单药治疗 PD-L1 表达 ≥ 50% 的转移性非小细胞肺癌 (NSCLC) 的真实世界数据:一项西班牙全国多中心队列研究 (CEMI-SPA 研究)

Masini, Silvia; Antoñanzas Basa, Monica; Calles, Antonio; Cabellos, Ruth Alvarez; De Elejoste Echebarria, Ibone; Traseira Puchol, Cristina; Martinez Kareaga, Mireia; Cabezon-Gutierrez, Luis; Escoin Perez, Maria Corina; Lage, Yolanda; Garcia Lorenzo, Ester; Navarro, Fatima; Sereno, Maria; Falagán Martínez, Sandra; García-Benito, Carme; Masfarre Pinto, Laura; Avila Andrade, Claudio; Sequero, Silvia; Mosquera Martinez, Joaquín; López-Martín, Ana; Azkárate Martínez, Aitor; Martín-Soberón, Maria Cruz; Lucia-Gozalvez, Clara; Rubio, Judit; Tallafigo, Leopoldo; Garrido, Alberto; Peressini, Melina; Torres-Jimenez, Javier; Zurera, María; Bote, Helena; Ponce, Santiago; Paz-Ares, Luis; Zugazagoitia, Jon; Baena, Javier

Palinopsia associated with the CDK4/6 inhibitor ribociclib during the first-line treatment of metastatic breast cancer: two case reports

CDK4/6抑制剂ribociclib一线治疗转移性乳腺癌期间出现视幻觉:两例病例报告

Martos, Tamara; Saint-Gerons, Marta; Masfarre, Laura; Castro-Henriques, Maria; Martinez-Garcia, Maria; Servitja, Sonia; Albanell, Joan

Post-exposure prophylaxis for HIV infection in sexual assault victims

性侵受害者的艾滋病毒感染暴露后预防

Inciarte, A; Leal, L; Masfarre, L; Gonzalez, E; Diaz-Brito, V; Lucero, C; Garcia-Pindado, J; León, A; García, F